HDAC9 and acute kidney injury: In this study, we assessed the therapeutic effect of TMP269, a highly selective class IIa HDAC inhibitor, on AKI and the mechanisms involved in two murine models-the first induced by folic acid and the second by ischemia/reperfusion.